annual total liabilities:
$139.66M-$54.32M(-28.00%)Summary
- As of today (June 22, 2025), ADMA annual total liabilities is $139.66 million, with the most recent change of -$54.32 million (-28.00%) on December 31, 2024.
- During the last 3 years, ADMA annual total liabilities has risen by +$4.58 million (+3.39%).
- ADMA annual total liabilities is now -28.92% below its all-time high of $196.49 million, reached on December 31, 2022.
Performance
ADMA Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$137.15M-$2.51M(-1.80%)Summary
- As of today (June 22, 2025), ADMA quarterly total liabilities is $137.15 million, with the most recent change of -$2.51 million (-1.80%) on March 31, 2025.
- Over the past year, ADMA quarterly total liabilities has dropped by -$60.02 million (-30.44%).
- ADMA quarterly total liabilities is now -31.48% below its all-time high of $200.17 million, reached on September 30, 2022.
Performance
ADMA quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ADMA Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.0% | -30.4% |
| 3 y3 years | +3.4% | -24.3% |
| 5 y5 years | +38.4% | +20.1% |
ADMA Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.9% | +3.4% | -31.5% | at low |
| 5 y | 5-year | -28.9% | +38.4% | -31.5% | +20.1% |
| alltime | all time | -28.9% | >+9999.0% | -31.5% | >+9999.0% |
ADMA Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $137.15M(-1.8%) |
| Dec 2024 | $139.66M(-28.0%) | $139.66M(-12.0%) |
| Sep 2024 | - | $158.73M(-15.6%) |
| Jun 2024 | - | $188.13M(-4.6%) |
| Mar 2024 | - | $197.17M(+1.6%) |
| Dec 2023 | $193.98M(-1.3%) | $193.98M(-1.8%) |
| Sep 2023 | - | $197.56M(+0.7%) |
| Jun 2023 | - | $196.26M(+0.6%) |
| Mar 2023 | - | $195.13M(-0.7%) |
| Dec 2022 | $196.49M(+45.5%) | $196.49M(-1.8%) |
| Sep 2022 | - | $200.17M(+9.7%) |
| Jun 2022 | - | $182.53M(+0.8%) |
| Mar 2022 | - | $181.10M(+34.1%) |
| Dec 2021 | $135.08M(+13.1%) | $135.08M(-0.6%) |
| Sep 2021 | - | $135.86M(+12.1%) |
| Jun 2021 | - | $121.22M(-1.6%) |
| Mar 2021 | - | $123.16M(+3.1%) |
| Dec 2020 | $119.42M(+18.4%) | $119.42M(+0.7%) |
| Sep 2020 | - | $118.60M(+3.4%) |
| Jun 2020 | - | $114.66M(+0.4%) |
| Mar 2020 | - | $114.19M(+13.2%) |
| Dec 2019 | $100.90M(+46.0%) | $100.90M(-0.8%) |
| Sep 2019 | - | $101.66M(+5.5%) |
| Jun 2019 | - | $96.37M(+41.5%) |
| Mar 2019 | - | $68.08M(-1.5%) |
| Dec 2018 | $69.11M(+2.1%) | $69.11M(-0.0%) |
| Sep 2018 | - | $69.14M(+4.8%) |
| Jun 2018 | - | $65.99M(-3.1%) |
| Mar 2018 | - | $68.11M(+0.6%) |
| Dec 2017 | $67.69M | $67.69M(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $59.82M(+5.0%) |
| Jun 2017 | - | $56.96M(+100.9%) |
| Mar 2017 | - | $28.35M(+0.7%) |
| Dec 2016 | $28.14M(+22.9%) | $28.14M(+1.8%) |
| Sep 2016 | - | $27.65M(-0.6%) |
| Jun 2016 | - | $27.83M(+20.7%) |
| Mar 2016 | - | $23.05M(+0.7%) |
| Dec 2015 | $22.89M(+8.9%) | $22.89M(-0.1%) |
| Sep 2015 | - | $22.91M(+13.0%) |
| Jun 2015 | - | $20.28M(-1.1%) |
| Mar 2015 | - | $20.50M(-2.5%) |
| Dec 2014 | $21.01M(+101.9%) | $21.01M(+31.0%) |
| Sep 2014 | - | $16.04M(+3.0%) |
| Jun 2014 | - | $15.58M(-2.9%) |
| Mar 2014 | - | $16.05M(+54.2%) |
| Dec 2013 | $10.41M(+69.7%) | $10.41M(+10.3%) |
| Sep 2013 | - | $9.44M(+5.3%) |
| Jun 2013 | - | $8.96M(+20.8%) |
| Mar 2013 | - | $7.42M(+21.0%) |
| Dec 2012 | $6.13M(>+9900.0%) | $6.13M(+279.0%) |
| Sep 2012 | - | $1.62M(+31.7%) |
| Jun 2012 | - | $1.23M(-2.4%) |
| Mar 2012 | - | $1.26M(>+9900.0%) |
| Dec 2011 | - | $5300.00(-45.9%) |
| Sep 2011 | - | $9800.00(0.0%) |
| Jun 2011 | $9800.00(-21.0%) | $9800.00(+69.0%) |
| Mar 2011 | - | $5800.00(+20.8%) |
| Dec 2010 | - | $4800.00(-61.3%) |
| Jun 2010 | - | $12.40K |
| Jun 2010 | $12.40K | - |
FAQ
- What is ADMA Biologics annual total liabilities?
- What is the all time high annual total liabilities for ADMA Biologics?
- What is ADMA Biologics annual total liabilities year-on-year change?
- What is ADMA Biologics quarterly total liabilities?
- What is the all time high quarterly total liabilities for ADMA Biologics?
- What is ADMA Biologics quarterly total liabilities year-on-year change?
What is ADMA Biologics annual total liabilities?
The current annual total liabilities of ADMA is $139.66M
What is the all time high annual total liabilities for ADMA Biologics?
ADMA Biologics all-time high annual total liabilities is $196.49M
What is ADMA Biologics annual total liabilities year-on-year change?
Over the past year, ADMA annual total liabilities has changed by -$54.32M (-28.00%)
What is ADMA Biologics quarterly total liabilities?
The current quarterly total liabilities of ADMA is $137.15M
What is the all time high quarterly total liabilities for ADMA Biologics?
ADMA Biologics all-time high quarterly total liabilities is $200.17M
What is ADMA Biologics quarterly total liabilities year-on-year change?
Over the past year, ADMA quarterly total liabilities has changed by -$60.02M (-30.44%)